Skip to content

Clinical trials

Phase 2 Adenocarcinoma of Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Phase: Phase 2 Clear all

156 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20025
20033
20046
200512
200612
200710
20085
20093
20104
20115
20127
20133
20142
201510
20167
20175
20184
20195
20206
20216
20224
20234
20244
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed88
Terminated22
Unknown status19
Recruiting11
Active, not recruiting8
Not yet recruiting5
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology14
National Cancer Institute (NCI)13
SWOG Cancer Research Network11
Novartis Pharmaceuticals8
Radiation Therapy Oncology Group5
Swiss Cancer Institute5
Shanghai Pulmonary Hospital, Shanghai, China4
Henan Cancer Hospital3
Masonic Cancer Center, University of Minnesota3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung156
Carcinoma, Non-Small-Cell Lung110
Lung Neoplasms99
Adenocarcinoma, Bronchiolo-Alveolar47
Neoplasm Metastasis4
Pleural Effusion, Malignant4
Adenocarcinoma3
Brain Neoplasms3
Carcinoma2
Carcinoma, Squamous Cell2

Trials

Showing 1 to 25 of 156. Each trial links to its page on Pharma Observatory.

56 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.